Ludovic R. Otterbein

Author

AstraZeneca (United Kingdom)

Also Known As

L OTTERBEIN, L. Otterbein, L.R. Otterbein, Ludovic Otterbein, Ludovic R. Otterbein, Otterbein, L.

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)Boston Biomedical Research Institute National Hellenic Research Foundation Centre National de la Recherche Scientifique

About

Ludovic R. Otterbein is an author at AstraZeneca (United Kingdom) specializing in biochemistry, medicinal chemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	494
2	Natural Sciences	5	5	538
3	Engineering	2	2	208
4	Health Sciences	1	1	41
5	Applied Physics	1	1	123

Ludovic R. Otterbein

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
The Crystal Structure of Uncomplexed Actin in the ADP State Ludovic R. Otterbein, Philip Graceffa, Roberto Domínguez Science	2001	524
<i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor Laurent Hennequin, J M Allen, J. Breed, Journal of Medicinal Chemistry Drug TargetPharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2006	358
Crystal structures of the vitamin D-binding protein and its complex with actin: Structural basis of the actin-scavenger system Ludovic R. Otterbein, Christophe Cosio, Philip Graceffa, Proceedings of the National Academy of Sciences	2002	154
Crystal Structures of S100A6 in the Ca2+-Free and Ca2+-Bound States Ludovic R. Otterbein, Jolanta Kordowska, Carlos Witte-Hoffmann, Structure Crystal StructureEngineeringPhysicsApplied PhysicsCa2+-bound States	2002	123
Molecular cloning of the cDNA encoding laccase from <i>Pycnoporus cinnabarinus</i> I‐937 and expression in <i>Pichia pastoris</i> Ludovic R. Otterbein, Éric Record, Sonia Longhi, European Journal of Biochemistry	2000	117
Heterologous production of a laccase from the basidiomycete in the dimorphic yeast Catherine Madzak, Ludovic R. Otterbein, Mohamed Chamkha, FEMS Yeast Research	2004	97
Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides S. Stokes, Robert Albert, Ed T. Buurman, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiosynthesisEngineeringBiochemistryNatural Sciences	2012	85
In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae Ed T. Buurman, Beth Andrews, Ning Gao, Journal of Biological Chemistry GlycobiologyEscherichia ColiAntimicrobial ChemotherapyDrug ResistanceMedical Microbiology	2011	41
Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors Alan M. Birch, Peter W. Kenny, Nikos G. Oikonomakos, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacotherapy	2006	40
Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies Paul R. O. Whittamore, Matthew S. Addie, Stuart N. L. Bennett, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryVitro SarNatural Sciences	2006	29

Page 1